H.U. Group Holdings 대차 대조표 상태

재무 상태 기준 확인 4/6

H.U. Group Holdings 의 총 주주 지분은 ¥136.1B 이고 총 부채는 ¥80.1B, 이는 부채 대 자기자본 비율을 58.9% 로 가져옵니다. 총자산과 총부채는 각각 ¥291.4B 및 ¥155.3B 입니다.

주요 정보

58.9%

부채 비율

JP¥80.10b

부채

이자 보상 비율	n/a
현금	JP¥47.02b
주식	JP¥136.08b
총 부채	JP¥155.29b
총 자산	JP¥291.37b

최근 재무 상태 업데이트

Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?

Jun 21

Recent updates

Analysts Have Been Trimming Their H.U. Group Holdings, Inc. (TSE:4544) Price Target After Its Latest Report

Jun 24

Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?

Jun 21

H.U. Group Holdings, Inc.'s (TSE:4544) Intrinsic Value Is Potentially 54% Above Its Share Price

Feb 28

재무 상태 분석

단기부채: 4544 의 단기 자산 ( ¥127.4B )이 단기 부채( ¥67.0B ).

장기 부채: 4544 의 단기 자산( ¥127.4B )이 장기 부채( ¥88.3B ).

부채 대 자본 내역 및 분석

부채 수준: 4544 의 순부채 대 자기자본 비율( 24.3% )은 satisfactory로 간주됩니다.

부채 감소: 4544 의 부채 대 자기자본 비율은 지난 5년간 39.5% 에서 58.9% 로 증가했습니다.

부채 범위: 4544 의 부채는 영업 현금 흐름 ( 22.1% )에 의해 잘 충당되었습니다.

이자 보장: 4544 의 부채에 대한 이자 지급이 EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.

H.U. Group Holdings 대차 대조표 상태

재무 상태 기준 확인 4/6

주요 정보

최근 재무 상태 업데이트

Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?

Recent updates

Now 21% undervalued after recent price drop

Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00

Upcoming dividend of JP¥62.00 per share

H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00

H.U. Group Holdings, Inc. to Report Q2, 2025 Results on Nov 08, 2024

H.U. Group Holdings (TSE:4544) Is Due To Pay A Dividend Of ¥62.00

Estimating The Fair Value Of H.U. Group Holdings, Inc. (TSE:4544)

Now 25% undervalued

Price target decreased by 8.1% to JP¥2,314

H.U. Group Holdings, Inc. and Fujirebio Launches the Fully Automated Lumipulse G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu

H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00

H.U. Group Holdings' (TSE:4544) Dividend Will Be ¥62.00

Final dividend of JP¥62.00 announced

H.U. Group Holdings, Inc. to Report Q1, 2025 Results on Aug 08, 2024

Analysts Have Been Trimming Their H.U. Group Holdings, Inc. (TSE:4544) Price Target After Its Latest Report

Full year 2024 earnings: EPS misses analyst expectations

Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?

Full year 2024 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc., Annual General Meeting, Jun 18, 2024

Now 21% undervalued after recent price drop

H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer

H.U. Group Holdings, Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Upcoming dividend of JP¥63.00 per share

H.U. Group Holdings, Inc.'s (TSE:4544) Intrinsic Value Is Potentially 54% Above Its Share Price

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

H.U. Group Holdings, Inc. to Report Q3, 2024 Results on Feb 09, 2024

H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems

H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 30%

Price target decreased by 9.4% to JP¥2,727

Upcoming dividend of JP¥62.00 per share at 4.7% yield

H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index (USD)

H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index (USD)

H.U. Group Holdings, Inc. to Report Q2, 2024 Results on Nov 09, 2023

Consensus EPS estimates increase by 17%

First quarter 2024 earnings released: JP¥19.66 loss per share (vs JP¥98.23 profit in 1Q 2023)

Now 20% undervalued after recent price drop

H.U. Group Holdings, Inc. to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

H.U. Group Holdings, Inc., Annual General Meeting, Jun 20, 2023

Upcoming dividend of JP¥63.00 per share at 4.7% yield

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: JP¥56.86 (vs JP¥105 in 3Q 2022)

H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023

H.U. Group Holdings, Inc. to Report Q3, 2023 Results on Feb 08, 2023

Second quarter 2023 earnings released: EPS: JP¥175 (vs JP¥196 in 2Q 2022)

Second quarter 2023 earnings released: EPS: JP¥175 (vs JP¥196 in 2Q 2022)

Upcoming dividend of JP¥62.00 per share

H.U. Group Holdings, Inc. to Report Q2, 2023 Results on Nov 09, 2022

Consensus forecasts updated

H.U. Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥98.23 (vs JP¥146 in 1Q 2022)

Now 20% undervalued

Price target decreased to JP¥3,137

Now 21% undervalued

Full year 2022 earnings: Revenues exceed analyst expectations

Price target decreased to JP¥3,055

Now 20% undervalued after recent price drop

H.U. Group Holdings, Inc. to Report Q1, 2023 Results on Aug 09, 2022

Consensus EPS estimates increase by 27%

H.U. Group Holdings, Inc. Provides Dividend Guidance for the Fiscal Year Ended March 31, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

H.U. Group Holdings, Inc., Annual General Meeting, Jun 21, 2022

Insufficient new directors

H.U. Group Holdings, Inc. Announces Board Changes

H.U. Group Holdings, Inc. to Report Fiscal Year 2022 Results on May 12, 2022

H.U. Group Holdings, Inc. Announces Launch of Fully Automated Lumipulse G ß-Amyloid 1-42 and ß-Amyloid 1-40 Plasma Assays for Research Use Only

Upcoming dividend of JP¥63.00 per share

Fujirebio Enters the Field of Fully Automated Blood-Based Alzheimer’s Disease Biomarker Testing with the Release of the Lumipulse® G Ptau 181 Plasma Assay for Research Use Only